Related Experiment Video
Updated: Jan 4, 2026

04:42
Treating Low Back Pain in Failed Back Surgery Patients with Multicolumn-lead Spinal Cord Stimulation
Published on: June 26, 2018
15.1K
Spinal Cord Stimulation for Failed Back Surgery Syndrome -- Patient Selection Considerations
Nicole Palmer1, Zhonghui Guan2, Nu Cindy Chai2
1University of California San Francisco Medical School, San Francisco, CA, USA.
Summary
Spinal cord stimulation (SCS) shows promise for failed back surgery syndrome (FBSS), particularly for leg pain. However, evidence on long-term benefits and patient selection requires further investigation due to potential biases and placebo effects.
Area of Science:
- Neurology
- Pain Management
- Surgical Outcomes
Background:
- Failed back surgery syndrome (FBSS) presents persistent pain post-back surgery, historically challenging to treat.
- Spinal cord stimulation (SCS) offers a promising therapeutic avenue for FBSS patients.
- Critical appraisal is needed to define optimal patient selection for SCS in FBSS.
Purpose of the Study:
- To systematically review the efficacy of spinal cord stimulation (SCS) for failed back surgery syndrome (FBSS).
- To identify patient characteristics influencing SCS outcomes, including work status, psychological factors, and demographics.
- To highlight areas needing further research in SCS for FBSS.
Main Methods:
- Systematic review of randomized controlled trials and cohort studies with matched controls.
- Synthesis of data on overall SCS efficacy for FBSS.
- Analysis of outcome variations based on patient descriptors like work status, psychological status, smoking, sex, and race.
Main Results:
- Eleven publications were reviewed, with seven showing potential funding or affiliation bias.
- SCS demonstrated statistically significant improvement in radiating leg pain in 3 of 4 studies.
- Improvement in functional status and quality of life was noted in RCTs, but data on psychological status, smoking, sex, or race was limited.
Conclusions:
- Accumulating evidence supports SCS efficacy in FBSS, especially for predominant leg pain.
- Potential bias from funding sources and limited long-term (beyond two years) efficacy data are significant weaknesses.
- Further research should focus on refining patient selection and understanding the substantial placebo effect in SCS for FBSS.

